SentreHEART, Inc. is a privately held medical device company that manufacturers the LARIAT(R) Suture Delivery Device for remote delivery of a pre-tied suture loop. Regulatory clearance for soft tissue ligation and approximation has been received in the US, Europe, and Canada. SentreHEART is committed to clinical evidence development and is currently sponsoring the FDA-approved prospective, multi-center, randomized controlled trial known as the aMAZE Trial. This Trial is designed to demonstrate the additive benefits of LARIAT LAA closure combined with pulmonary vein isolation as a means of improving outcomes in patients with persistent or longstanding persistent atrial fibrillation.
View Top Employees from SentreHEART, Inc.Website | http://www.sentreheart.com |
Revenue | $16 million |
Funding | $73.8 million |
Employees | 22 (7 on RocketReach) |
Founded | 2005 |
Phone | (650) 354-1200 |
Fax | (650) 354-1204 |
Industry | Medical Devices, Medical Devices & Equipment, Health Care, Manufacturing, Medical, Medical Device |
Web Rank | 11 Million |
Keywords | Sentreheart Sweden, Medical Device Companies In Bay Area, Sentreheart |
Competitors | Biometrix, IlluminOss Medical Inc., OrthAlign, Inc., Tracoe Medical GmbH, TriSalus Life Sciences |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular SentreHEART, Inc. employee's phone or email?
The SentreHEART, Inc. annual revenue was $16 million in 2023.
Greg Fung is the Vice President Research and Development of SentreHEART, Inc..
7 people are employed at SentreHEART, Inc..
SentreHEART, Inc. is based in Redwood City, California.
The NAICS codes for SentreHEART, Inc. are [33, 339].
The SIC codes for SentreHEART, Inc. are [38, 384].